GRK2 Inhibitor 2

Overview

GRK2 Inhibitor 2 is an orally active and selective G protein-coupled receptor kinase 2 ( GRK ) inhibitor with an IC 50 of 19 nM. GRK2 Inhibitor 2 also inhibits Aurora-A with an IC 50 of 137 nM. GRK2 Inhibitor 2 can be used in the study of congestive heart failure (HF).

Application

Products | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Hypertension | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Aurora Kinase | Products > Signaling Pathways > G Protein-coupled Receptor Kinase (GRK)

Product Information

• Catalog No.: HY-156863
• CAS No.: 2592436-21-8
• Molecular Formula: C19H16N4O2
• Molecular Weight: 332.36
• Purity: 99.92%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (7.52 mM); Clear solution
• Availability: In-stock

Source

Original product source